Popovits Kimberly J 4

What Happened Kimberly J. Popovits, a director of Exact Sciences Corporation, had two dispositions to the issuer on 2026-03-23 totaling 16,381 shares (6,725 + 9,656). Under the merger agreement with Abbott Laboratories, each share of Exact common stock was converted into the right to receive $105.00 in cash, so the shares converted into approximately $1,720,005 in merger consideration (before any applicable tax withholding). This is a corporate cash-out due to the merger, not an open-market sale.

Key Details

• Transaction date: 2026-03-23 (Effective Time of the merger).
• Price per share: $105.00 (merger consideration); total proceeds ≈ $1,720,005 before withholding.
• Shares involved: 6,725 and 9,656 (total 16,381).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — shares converted to $105 cash per the Merger Agreement; F2 — restricted/vesting shares deemed fully vested and converted and subject to applicable tax withholding.
• Filing timeliness: Reported on 2026-03-23 (same date as the transaction), indicating a timely Form 4 filing in the provided record.

Context This was a disposition to the issuer as part of the corporate merger (Badger Merger Sub I merged into Exact Sciences, making Exact a wholly owned subsidiary of Abbott). Such transactions reflect the deal consideration rather than an insider decision to trade; restricted shares were treated as vested and converted under the merger terms.